SCHEMBL18504081

SCHEMBL18504081

c1cc(-c2cccc(-c3cc4ccccc4c(-c4ccc(-c5ccncc5)cc4)n3)c2)cc(-c2ccc3c4ccccc4c4ccccc4c3c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.46
IMPDH2 P12268 1/20 0.41
PRKCH P24723 1/20 0.40
PRKCE Q02156 1/20 0.40
DHODH Q02127 1/20 0.39
PIK3CA P42336 1/20 0.39
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
MAPK13 O15264 3/20 0.38
MAPK12 P53778 3/20 0.38
MAPK11 Q15759 3/20 0.38
MAPK14 Q16539 3/20 0.38
GCGR P47871 2/20 0.38
MAPK8 P45983 1/20 0.38
MAPK9 P45984 1/20 0.38
MAPK10 P53779 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504077 0.99 MKNK1 (0.43) MKNK1IMPDH2PRKCHPRKCEDHODH
SCHEMBL18503964 0.93 MKNK1 (0.49) MKNK1IMPDH2PRKCHPRKCEDHODH
SCHEMBL18504023 0.92 MKNK1 (0.48) MKNK1IMPDH2PRKCHPRKCEDHODH
SCHEMBL18504050 0.92 KDM4E (0.40) MKNK1DHODHPIK3CAHSD17B1HSD17B2
SCHEMBL18503979 0.92 MKNK1 (0.47) MKNK1IMPDH2PRKCHPRKCEDHODH
SCHEMBL18504021 0.90 MKNK1 (0.46) MKNK1IMPDH2PRKCHPRKCEDHODH
SCHEMBL18504048 0.90 KDM4E (0.41) MKNK1DHODHPIK3CAHSD17B1HSD17B2
SCHEMBL18504087 0.90 PIK3CA (0.41) MKNK1IMPDH2PRKCHPRKCEDHODH
SCHEMBL18504053 0.89 IDO1 (0.38) DHODHHSD17B1HSD17B2KDM4EALDH1A1
SCHEMBL18504159 0.88 KDM4E (0.41) MKNK1IMPDH2PRKCHPRKCEPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 MKNK1 2201/4885IMPDH2 2802/4885PRKCH 4315/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 MKNK1 2201/4885IMPDH2 2802/4885PRKCH 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.